Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Other Gross PP&E Adjustments (2018 - 2025)

Capricor Therapeutics has reported Other Gross PP&E Adjustments over the past 12 years, most recently at $9.9 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $9.9 million for Q4 2025, up 28.91% from a year ago — trailing twelve months through Dec 2025 was $9.9 million (up 28.91% YoY), and the annual figure for FY2025 was $9.9 million, up 28.91%.
  • Other Gross PP&E Adjustments for Q4 2025 was $9.9 million at Capricor Therapeutics, up from $1.8 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for CAPR hit a ceiling of $11.2 million in Q2 2025 and a floor of -$269536.0 in Q4 2021.
  • Median Other Gross PP&E Adjustments over the past 5 years was $4.2 million (2023), compared with a mean of $4.6 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 117.17% in 2021 and later skyrocketed 1368.73% in 2022.
  • Capricor Therapeutics' Other Gross PP&E Adjustments stood at -$269536.0 in 2021, then skyrocketed by 1368.73% to $3.4 million in 2022, then soared by 67.17% to $5.7 million in 2023, then surged by 34.68% to $7.7 million in 2024, then rose by 28.91% to $9.9 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $9.9 million (Q4 2025), $1.8 million (Q3 2025), and $11.2 million (Q2 2025) per Business Quant data.